News

Rizaport, 5 mg and 10 mg, is an oral thin film formulation of rizatriptan benzoate. It is being developed by RedHill Biopharma and IntelGenx. It is the first

If approved, etelcalcetide will be the first calcimimetic agent that can be administered intravenously. Amgen executive vice president of research and development Sean Harper said: "We’re pleased that

Xtampza ER is an extended-release, oral formulation of oxycodone, in development to manage pain severe enough for daily, long-term opioid treatment and for which alternative treatment options are

Sulfatinib inhibits the tyrosine kinase activity related with the vascular endothelial growth factor receptor (VEGFR) and fibroblast growth receptor (FGFR), which plays a role in tumour growth. The

US-based ZS Pharma develops and commercializes highly selective, non-absorbed drugs for the treatment of renal, cardiovascular, liver and metabolic disorders. The company employs about 200 people across three

The investigational drug SM04690 is a small molecule inhibitor of the Wnt pathway. The approximately 400 patient trial will study three different doses of SM04690 against a placebo,

The study, which appears in the journal ACS Nano, shows how the nanoparticle system targets the precise cells infected by the bacteria and maximizes the amount of drug

This innovative funding approach, into a cancer with low survival rates and in urgent need of better treatments, will support over 24 researchers across the UK and US

Launched in India in 1980, Little’s is present across a wide range of products including – baby feeding bottles, baby skin-care, baby grooming accessories, baby apparels and baby